Monday, December 23, 2024

NIH to award contract for Software Maintenance and Support for HALO 10 Module 2 Seat License

Updated July 27, 2021

Notice ID: 75N95021Q00257

“The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Aging (NIA), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Indica Labs for Software Maintenance and Support for HALO 10 Module 2 Seat License.”

“This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-(b)(1) …”

Read more here.


Posted June 24, 2021

Notice ID: 75N95021Q00257

“Background:  Use of HALO will facilitate ongoing collaborations with intramural collaborators at NINDS (National Institute of Neurological Disorders and Stroke) and NCI (National Cancer Institute) on the Bethesda campus.”

“Purpose and Objectives: Halo combines advanced image management with HALO image analysis and allows secure anywhere, anytime access to study data slides and analysis results from any NIA (National Institute on Aging) computer. This equipment is used by multiple labs and multiple users thus increasing the chances of malfunction.  HALO 10 Module 2-Seat License (ASSET771)”

“Project requirements:

  • Software maintenance and support for Halo 10 Module 2-Seat License includes technical and application support, and available product upgrades.
  • Qualified Indica Labs technicians and support staff.”

“Anticipated period of performance:

  • Base Year: 9/30/2021 – 9/29/2022
  • Option Year 1: 9/30/2022 – 9/29/2023
  • Option Year 2: 9/30/2023 – 9/29/2024″

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required